KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Invested Capital (2016 - 2025)

Exact Sciences (EXAS) has disclosed Invested Capital for 16 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital changed 0.05% to $2.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 billion, a 0.05% change, with the full-year FY2025 number at $2.4 billion, changed 0.05% from a year prior.
  • Invested Capital was $2.4 billion for Q4 2025 at Exact Sciences, down from $2.5 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $3.6 billion in Q1 2021 to a low of $2.4 billion in Q1 2025.
  • A 5-year average of $3.0 billion and a median of $3.2 billion in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: soared 99.78% in 2021, then fell 24.82% in 2024.
  • Exact Sciences' Invested Capital stood at $3.4 billion in 2021, then fell by 10.17% to $3.0 billion in 2022, then increased by 5.0% to $3.2 billion in 2023, then dropped by 24.82% to $2.4 billion in 2024, then decreased by 0.05% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Invested Capital are $2.4 billion (Q4 2025), $2.5 billion (Q3 2025), and $2.5 billion (Q2 2025).